Literature DB >> 1740296

Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma.

K Sheibani1, J M Esteban, A Bailey, H Battifora, L M Weiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1740296     DOI： 10.1016/0046-8177(92)90231-q

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  13 in total

1.  Diagnostic utility of immunohistochemical panel in various thyroid pathologies.

Authors:  Arturs Ozolins; Zenons Narbuts; Ilze Strumfa; Guna Volanska; Janis Gardovskis
Journal:  Langenbecks Arch Surg       Date:  2010-07-18       Impact factor: 3.445

2.  HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.

Authors:  A D Kennedy; G King; K M Kerr
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

3.  Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.

Authors:  K M Amin; L A Litzky; W R Smythe; A M Mooney; J M Morris; D J Mews; H I Pass; C Kari; U Rodeck; F J Rauscher
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

4.  An autopsy case of malignant mesothelioma with osseous and cartilaginous differentiation: bone morphogenetic protein-2 in mesothelial cells and its tumor.

Authors:  Y Kiyozuka; H Miyazaki; K Yoshizawa; H Senzaki; D Yamamoto; K Inoue; K Bessho; Y Okubo; K Kusumoto; A Tsubura
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

5.  Subcutaneous metastasis of peritoneal mesothelioma diagnosed by fine-needle aspiration.

Authors:  Lina Pappa; Melpomeni Machera; Eleni Tsanou; Constantina Damala; Dimitrios Peschos; Maria Bafa; Vassiliki Malamou-Mitsi
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

6.  Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.

Authors:  M Miettinen; P Kärkkäinen
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

7.  Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes.

Authors:  László Krenács; Judit Tóth-Lipták; Judit Demeter; Klára Piukovics; Zita Borbényi; Péter Gogolák; Eszter Sári; Enikő Bagdi
Journal:  Virchows Arch       Date:  2013-10-05       Impact factor: 4.064

8.  Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.

Authors:  H Moch; M Oberholzer; P Dalquen; W Wegmann; F Gudat
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages.

Authors:  Derya Gümürdülü; E Handan Zeren; Philip T Cagle; Fazilet Kayasel uk; Nazan Alparslan; Ali Kocabas; Ilhan Tuncer
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

10.  OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.

Authors:  C Edwards; J Oates
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.